10.20.03: Rodman & Renshaw Techvest Healthcare Conference Issue
Three analysts and top management from ninety sector firms examine the Healthcare sector in this 300-page Rodman & Renshaw Techvest Healthcare Conference Issue from The Wall Street Transcript.
  1. Biotechnology Stocks - In an in-depth (3,700 words) Analyst Interview, Navdeep S. Jaikaria, a Senior Biotechnology Analyst at Rodman & Renshaw, examines the outlook for the sector and shares specific stock recommendations.
  2. Investment Opportunities in Biotechnology - In an in-depth (2,800 words) Analyst Interview, Elemer Piros, a Senior Biotechnology Analyst with Rodman & Renshaw, examines the outlook for the sector and shares specific stock recommendations.
  3. Investing in Biotechnology - In an in-depth (3,600 words) Analyst Interview, David E. Wood, a Senior Biotechnology Analyst at Rodman & Renshaw, examines the outlook for the sector and shares specific stock recommendations.
  4. CEO interviews (average 2,500 words). Top management of ninety - sector firms examine the outlook for their firm and the sector. Firms include:
    Aastrom Biosciences, Inc., ADVENTRX Pharmaceuticals, Inc., Aksys, Ltd., Alteon Inc., Anika Therapeutics, Inc., ArQule, Inc., AtheroGenics, Inc., AVANIR Pharmaceuticals, AVI BioPharma, Inc., Avidex Limited, Axonyx Inc., BioAxone Therapeutic Inc., BioSante Pharmaceuticals, Inc., Biosyntech, Inc. , Celmed Biosciences Inc., CEL-SCI Corporation, Celsion Corporation, Cepheid, Chrysalis BioTechnology, Inc., Ciphergen Biosystems, Inc., CollaGenex Pharmaceuticals, Inc., Confluent Surgical, Inc., Cortex Pharmaceuticals, Inc., Cyclacel Limited, Cypress Bioscience Inc., Cytogen Corporation, CytRx Corporation, DOV Pharmaceutical, Inc., Dyax Corp., EluSys Therapeutics, Inc., Encelle, Inc., Epoch Biosciences, Inc., ES Cell International Pte Ltd., Esperion Therapeutics, Inc., Gamida-Cell Ltd., Genaissance Pharmaceuticals, Genetronics Biomedical Corp., Genome Therapeutics Corp., Genta Incorporated, Hollis-Eden Pharmaceuticals, Inc., Immtech International, Inc., Inion Ltd., InKine Pharmaceutical Company, Intercell AG, Interface Biologics Inc., Introgen Therapeutics, Inc., Isis Pharmaceuticals, Inc., Keryx Biopharmaceuticals, Inc., Life Medical Sciences, Inc., Lorus Therapeutics Inc., MacroPore Biosurgery, Inc., Matritech, Inc., MethylGene Inc., MGI PHARMA, INC., Musculoskeletal Transplant Foundation, Nanosphere, Inc., Nastech Pharmaceutical Co. Inc., NeoPharm, Inc., NeoRX Corporation, Neose Technologies Inc., Neurogen Corporation, Northfield Laboratories Inc. , Nucleonics Inc., Nuvelo Inc. , Onyx Pharmaceuticals, Inc., OraSure Technologies, Inc., Ortec International, Inc., OsteoBiologics, Inc., OXiGENE, Inc., Pharmacopeia, Inc., Pharmos Corporation, Point Therapeutics, Inc., PolyMedix Inc., Proneuron Biotechnologies, Inc., Questcor Pharmaceuticals, Inc., ReGen Biologics, Inc., Regeneration Technologies, Inc., RegeneRx Biopharmaceuticals, Revivicor, Inc., Rigel Pharmaceuticals, Inc., RITA Medical Systems, Inc., Salmedix, Inc., Seattle Genetics, Inc., StemCells, Inc., Stressgen Biotechnologies Corp., Tanox, Inc., Targeted Genetics Corp., Tissue Transformation Technologies, Transave, Inc., Vasomedical, Inc.
    5. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been read and used by investors and industry executives for nearly 40 years. It's a vital and unique tool for doing company and industry research - as part of a stock purchase decision or as part of a market analysis.

Investors:
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. Find out where they agree, and where they disagree on stock recommendations. Money manager interviews provide the view from the buy-side. And CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Industry Executives:
Get the insider view on the sector from Wall Street Analysts and Company CEO's. Company strategies, growth ambitions, new products and markets, management - these and much more are discussed by the top executives in the industry. TWST's reports should be a key part of any industry research.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE